Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The infectious bursal disease virus VP2 protein is the principal structural protein forming the icosahedral outer shell of the infectious bursal disease virus (IBDV), an avian pathogen causing immunosuppressive disease in poultry[1][2][3]. VP2 accounts for about 51% of the viral virion by mass and self-assembles into trimers, which are fundamental building blocks of the viral capsid[1][2]. The protein comprises three major domains: a conserved basement (base) domain, a shell domain, and a prominent projection (protrusion) domain, the latter of which harbors hypervariable regions responsible for strain-specific antigenic differences[1][3]. The surface-exposed loops of the protrusion domain present the primary epitopes for neutralizing antibodies and are frequent sites of antigenic variation, impacting both immune recognition and virulence[1][3][4][5]. During virus maturation, VP2 is produced from a precursor (pVP2) via proteolytic processing[5]. VP2 is a main target in the development of subunit and virus-like particle vaccines, as well as diagnostic reagents aimed at controlling IBDV outbreaks in poultry[7][8]. No direct small-molecule drugs are known to target VP2, but immunization strategies depend on its structure and antigenic variation.
Induction of host neutralizing antibodies (antigenic target for vaccine immunogens); Target for passive immunization with monoclonal antibodies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Infectious bursal disease virus VP2 protein (VP2).